Concepedia

José-Luis Díaz

JD

Statistics

Publications

17

Citations

816

H-Index

15

Active since

1997

Affiliations

Almirall (Spain)(Current)

Neurocrine Biosciences (United States)

Idera Pharmaceuticals (United States)

Novartis (Switzerland)

José-Luis Díaz is an author at Almirall (Spain) specializing in pharmacology, medicinal chemistry, and pharmacy.

Publications per year

1997–2019

17

Publications

17

Dimerization Properties of Human BAD

Sabine Ottilie, José-Luis Díaz, William A. Horne et al. · Journal of Biological Chemistry · 1997 · 147 citations · Full text

, , +15

A Common Binding Site Mediates Heterodimerization and Homodimerization of Bcl-2 Family Members

José-Luis Díaz, Tilman Oltersdorf, William A. Horne et al. · Journal of Biological Chemistry · 1997 · 129 citations · Full text

, , +15

First-in-Class Pan Caspase Inhibitor Developed for the Treatment of Liver Disease

Steven D. Linton, Teresa Aja, Robert A. Armstrong et al. · Journal of Medicinal Chemistry · 2005 · 106 citations

, , +14

From State-to-Trait Meditation: Reconfiguration of Central Executive and Default Mode Networks

Clemens Bauer, Susan Whitfield‐Gabrieli, José-Luis Díaz et al. · eNeuro · 2019 · 82 citations · Full text

, , +17

2-Amino-<i>N</i>-pyrimidin-4-ylacetamides as A<sub>2A</sub>Receptor Antagonists: 1. Structure−Activity Relationships and Optimization of Heterocyclic Substituents

Deborah H. Slee, Yongsheng Chen, Xiaohu Zhang et al. · Journal of Medicinal Chemistry · 2008 · 43 citations · Full text

, , +15

1–5 of 17